Serum levels of IgG4 and soluble interleukin-2 receptor in patients with coronary artery disease

Clinica Chimica Acta

Volumn 413, Issue 5-6, 2012, Pages 577-581

  Sakamoto, Aiko ^a   Ishizaka, Nobukazu ^a,b   Saito, Kan ^a   Imai, Yasushi ^a   Morita, Hiroyuki ^a   Koike, Kazuhiko ^a   Kohro, Takahide ^a   Nagai, Ryozo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Biomarkers; Coronary artery disease; IgG4 related systemic sclerosing disease; Lymphocyte activation

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN G4; SOLUBLE INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ESTIMATED GLOMERULUS FILTRATION RATE; FEMALE; HUMAN; HYPERTENSION; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RENAL SYSTEM PARAMETERS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECEPTORS, INTERLEUKIN-2; SOLUBILITY;

EID: 84856234262     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.11.023     Document Type: Article

References (33)

1. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006, 47:C7-C12.
2. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
3. Koch A.E., Haines G.K., Rizzo R.J., et al. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 1990, 137:1199-1213.
4. Bachmann M.F., Oxenius A. Interleukin 2: from immunostimulation to immunoregulation and back again. EMBO Rep 2007, 8:1142-1148.
5. Harrington D.S., Patil K., Lai P.K., et al. Soluble interleukin 2 receptors in patients with malignant lymphoma. Arch Pathol Lab Med 1988, 112:597-601.
6. Dejica D. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy. Roum Arch Microbiol Immunol 2001, 60:183-201.
7. Semenzato G., Cipriani A., Trentin L., et al. High serum levels of soluble interleukin-2 receptors in sarcoidosis. Sarcoidosis 1987, 4:25-27.
8. Zerler B. The soluble interleukin-2 receptor as a marker for human neoplasia and immune status. Cancer Cells 1991, 3:471-479.
9. Hamano H., Kawa S., Horiuchi A., et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001, 344:732-738.
10. Yamamoto M., Takahashi H., Ohara M., et al. A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease. Mod Rheumatol 2006, 16:335-340.
11. Miyajima N., Koike H., Kawaguchi M., et al. Idiopathic retroperitoneal fibrosis associated with IgG4-positive-plasmacyte infiltrations and idiopathic chronic pancreatitis. Int J Urol 2006, 13:1442-1444.
12. Tabata T., Kamisawa T., Takuma K., et al. Serum IgG4 concentrations and IgG4-related sclerosing disease. Clin Chim Acta 2009, 408:25-28.
13. Bateman A.C., Deheragoda M.G. IgG4-related systemic sclerosing disease - an emerging and under-diagnosed condition. Histopathology 2009, 55:373-383.
14. Kasashima S., Zen Y. IgG4-related inflammatory abdominal aortic aneurysm. Curr Opin Rheumatol 2011, 23:18-23.
15. Stone J.H., Khosroshahi A., Hilgenberg A., et al. IgG4-related systemic disease and lymphoplasmacytic aortitis. Arthritis Rheum 2009, 60:3139-3145.
16. Matsumoto Y., Kasashima S., Kawashima A., et al. A case of multiple immunoglobulin G4-related periarteritis: a tumorous lesion of the coronary artery and abdominal aortic aneurysm. Hum Pathol 2008, 39:975-980.
17. Maturen KE, Sundaram B, Marder W, et al. Coronary Artery Involvement in Idiopathic Retroperitoneal Fibrosis: Computed Tomographic Findings. J Thorac Imaging in press, doi:. doi:10.1097/RTI.0b013e318213bcad.
18. Sone H., Ito H., Ohashi Y., et al. Obesity and type 2 diabetes in Japanese patients. Lancet 2003, 361:85.
19. Neri Serneri G.G., Prisco D., Martini F., et al. Acute T-cell activation is detectable in unstable angina. Circulation 1997, 95:1806-1812.
20. Olsson A.G., Schwartz G.G., Jonasson L., et al. Are early clinical effects of cholesterol lowering mediated through effects on inflammation?. Acta Physiol Scand 2002, 176:147-150.
21. Satoh D., Inami N., Shimazu T., et al. Soluble TRAIL prevents RANTES-dependent restenosis after percutaneous coronary intervention in patients with coronary artery disease. J Thromb Thrombolysis 2010, 29:471-476.
22. Wadwa R.P., Kinney G.L., Ogden L., et al. Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes. Int J Biochem Cell Biol 2006, 38:996-1003.
23. Takahashi M., Shimizu T., Inajima T., et al. A case of localized IgG4-related thoracic periarteritis and recurrent nerve palsy. Am J Med Sci 2011, 341:166-169.
24. Sakamoto A, Nagai R, Saito K, et al. Idiopathic retroperitoneal fibrosis, inflammatory aortic aneurysm, and inflammatory pericarditis - Retrospective analysis of 11 case histories. J Cardiol in press, doi:. doi:10.1016/j.jjcc.2011.07.014.
25. Tanigawa J, Daimo M, Murai M, et al. IgG4-related coronary periarteritis in patients presenting with myocardial ischemia. Hum Pathol in press.
26. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-1397.
27. Veselka J., Prochazkova S., Duchonova R., et al. Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test. Coron Artery Dis 2002, 13:151-154.
28. Azar R.R., Aoun G., Fram D.B., et al. Relation of C-reactive protein to extent and severity of coronary narrowing in patients with stable angina pectoris or abnormal exercise tests. Am J Cardiol 2000, 86:205-207.
29. Abdelmouttaleb I., Danchin N., Ilardo C., et al. C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 1999, 137:346-351.
30. Ridker P.M., Rifai N., Pfeffer M.A., et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) investigators. Circulation 1999, 100:230-235.
31. Plenge J.K., Hernandez T.L., Weil K.M., et al. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation 2002, 106:1447-1452.
32. Fliser D., Buchholz K., Haller H. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation 2004, 110:1103-1107.
33. Neild G.H., Rodriguez-Justo M., Wall C., et al. Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med 2006, 4:23.